152 related articles for article (PubMed ID: 11568556)
21. The stem cell hypothesis in head and neck cancer.
Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
23. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
[TBL] [Abstract][Full Text] [Related]
24. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
26. Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy.
Gál B; Veselý M; Čolláková J; Nekulová M; Jůzová V; Chmelík R; Veselý P
PLoS One; 2017; 12(8):e0183399. PubMed ID: 28846747
[TBL] [Abstract][Full Text] [Related]
27. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
[TBL] [Abstract][Full Text] [Related]
28. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
30. Nucleostemin expression in squamous cell carcinoma of the head and neck.
Cada Z; Boucek J; Dvoranková B; Chovanec M; Plzák J; Kodets R; Betka J; Pinot GL; Gabius HJ; Smetana K
Anticancer Res; 2007; 27(5A):3279-84. PubMed ID: 17970071
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis.
Xu XC; Lee JS; Lippman SM; Ro JY; Hong WK; Lotan R
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):871-6. PubMed ID: 8634660
[TBL] [Abstract][Full Text] [Related]
32. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status.
Garcia Pedrero JM; Fernandez MP; Morgan RO; Herrero Zapatero A; Gonzalez MV; Suarez Nieto C; Rodrigo JP
Am J Pathol; 2004 Jan; 164(1):73-9. PubMed ID: 14695321
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine differentiation in head and neck squamous cell carcinoma.
Schartinger VH; Falkeis C; Laimer K; Sprinzl GM; Riechelmann H; Rasse M; Virgolini I; Dudás J
J Laryngol Otol; 2012 Dec; 126(12):1261-70. PubMed ID: 23050666
[TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma.
Ichinose J; Shinozaki-Ushiku A; Takai D; Fukayama M; Nakajima J
Expert Rev Anticancer Ther; 2016; 16(4):403-10. PubMed ID: 26813704
[TBL] [Abstract][Full Text] [Related]
35. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
[TBL] [Abstract][Full Text] [Related]
36. Protein biomarker discovery for head and neck cancer.
Schaaij-Visser TB; Brakenhoff RH; Leemans CR; Heck AJ; Slijper M
J Proteomics; 2010 Sep; 73(10):1790-803. PubMed ID: 20139037
[TBL] [Abstract][Full Text] [Related]
37. [Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck].
Golusiński W; Golusiński P; Stańczak J; Kłosin J
Otolaryngol Pol; 2004; 58(4):777-84. PubMed ID: 15603389
[TBL] [Abstract][Full Text] [Related]
38. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
Clin Cancer Res; 2004 Dec; 10(24):8451-9. PubMed ID: 15625067
[TBL] [Abstract][Full Text] [Related]
39. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck.
McCaffery JD; Gapany M; Faust RA; Davis AT; Adams GL; Ahmed K
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):283-8. PubMed ID: 9076234
[TBL] [Abstract][Full Text] [Related]
40. Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck.
Fazekas-May M; Suen JY; Yeh YC; Yeh HW; Milligan LB
Head Neck; 1990; 12(5):411-6. PubMed ID: 2211102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
